MALARIA: CLINICAL DIAGNOSIS, TREATMENT AND PROPHYLAXIS. PROBLEMS AND SUCCESS
Abstract
Malaria remains one of the most important problems of health organizations for 100 countries in Asia, Africa and South America. Every year in the world about 300 to 500 million clinical conditions of Malaria and from 1.5 to 2.7 million people especially children up to 5 years, every year die from it. Not minding the success in the area of biology epidemiological study and clinical problems of the disease. In the present people die from malaria compared to 30 years ago. The highest level of the disease and death rates comes from the region on the territories that have been eliminated earlier, the number of increase malaria delivery and the second condition of delivery continues to increase. In the article is been presented modern ways in the areas of synthesis of new drugs for the treatment and prophylaxis of malaria and also new methods of diagnosis. The most important perspective for treatment and prophylaxis of malaria is taking different drug forms Artemizin, combination of Mefloxin and Artemizin, Alovakvon with Proguanium and other combination.
Downloads
References
2. Alnwick D. // Bull Wrld Hlth Org. 2000. P. 1377
3. Djimde A, Doumbo OK, Cortese JF et al. // N Engl J Med. 2001. P. 257-263.
4. International Travel and Health Vaccination requirements and health advice. WHO, Geneva, 1999. 104 p.
5. Malarone for Malaria Treatment and Prophylaxis. CDC Travellers’Health, October 11, 2000.
6. Malaria Diagnosis: New Perspectives. WHO / CDS / RBM / 2000 WHO, Geneva, 2000.
7. Olliaro P. // TDR News. 2001. № 64. P. 9-10.
8. Riley EM. // Mem Inst Oswaldo Cruz. 2000. Suppl 1. P. 25-32.
9. Schluesener HJ, Kremsner PG, Meyermann R. // Acta Neuropathol. 2001. P. 65-68.
10. Second Interregional Malaria Coordination Meeting. Baku, Azerbaijan, 31 May - 1 June 2000
The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
